Nearly one-fourth of ICD implants failed to meet implantation criteria

Ellis, Brian
February 2011
Cardiology Today;Feb2011, Vol. 14 Issue 2, p1
The article discusses a study which found out that non-evidence based implantation of an implantable cardioverter defibrillator (ICD) could increase the risk of in-hospital death and post-procedural complications.


Related Articles

  • RESYNCHRONIZATION THERAPY IN PATIENTS WITH HEART FAILURE. Kostić, Tomislav; Perišić, Zoran; Koraćević, Goran; Stanojević, Dragana; Milić, Dragan; Mitov, Vladimir; Pavlović, Milan; Šalinger Martinović, Sonja; Todorović, Lazar; Ćirić Zdravković, Snežana; Golubović, Mladjan // Acta Medica Medianae;Jun2013, Vol. 52 Issue 2, p10 

    Prognosis in heart failure (HF) is poor and mortality widely ranges - 15-60% per year. Cardiac resynchronization therapy (CRT) is a therapeutic concept for patients who have NYHA III or IV class, LVEF ≤ 35%, left bundle branch block with wide QRS ≥ 120ms and ventricular dyssynchrony...

  • Utilidad del desfibrilador automático implantable en la prevención de muerte súbita. Resultados de la medicina basada en evidencia. González, Celso Mendoza // Archivos de Cardiología de México;abr-jun2007supplement 2, Vol. 77, p44 

    A great percentage of patients who have suffered a myocardial infarction have ventricular left dysfunction. In agreement with the different prospective studies, many of these patients will have an event of ventricular arrhythmias that does them candidates for receiving a strategy of primary or...

  • Heartbeat: Highlights from this issue. Otto, Catherine M. // Heart;Sep2015, Vol. 101 Issue 17, p1347 

    A correction to the article "Application of a mortality risk score in a general population of patients with an implantable cardioverter defibrillator (ICD)" that was published in a previous issue is presented.

  • Update on implantable cardioverter-defibrillators. Sadovsky, Richard // American Family Physician;2/15/1997, Vol. 55 Issue 3, p936 

    Focuses on a study by A. Raviele, published in a 1996 edition of the `American Journal of Cardiology,' which highlighted the implantation of cardioverter-defibrillators in the treatment of survivors of cardiac arrest who failed to respond adequately to pharmacologic and surgical interventions....

  • Three-year mortality reduced in Medicare beneficiaries with HF after ICD implantation.  // Cardiology Today;Jan2010, Vol. 13 Issue 1, p1 

    The article discusses a study on reduced mortality of Medicare patients with heart failure (HF) who received implantable cardioverter defibrillator (ICD) conducted by a team led by A. Fernandez, published in a 2009 issue of "Circulation: Heart Failure."

  • Primary prevention implantable cardioverter defibrillators are effective in preventing overall mortality in older patients. Al-Khatib, Sana M. // Evidence Based Medicine;Dec2015, Vol. 20 Issue 6, p217 

    The article presents a study which examined the effectiveness of primary prevention implantable cardioverter defibrillator (ICD) as a life-saving therapy for patients with systolic heart failure and other acute comorbidities, particularly in older patients. Data used in the study were from the...

  • A prophylactically implanted cardioverter defibrillator reduced all-cause mortality in myocardial infarction. Hlatky, Mark A. // ACP Journal Club;Nov/Dec2002, Vol. 137 Issue 3, p81 

    Discusses research being done on the efficacy of implanted cardioverter defibrillator and conventional therapy in reducing mortality in patients with myocardial infarction. Reference to study by A.J. Moss and colleagues, published in the 2002 issue of the 'New England Journal of Medicine';...

  • Home monitoring reduces inappropriate ICD shocks by 52%.  // British Journal of Hospital Medicine (17508460);Feb2013, Vol. 74 Issue 2, p70 

    The article reports Biotronik, has published the clinical results of the trial Effectiveness and Cost of ICD Follow-Up Schedule with Telecardiology (ECOST), which states that home monitoring reduces inappropriate implantable cardioverter-defibrillators (ICD) shocks by 52 percent.

  • Cardiac Devices May Benefit Healthier Heart Patients.  // Heart Advisor;Oct2014, Vol. 17 Issue 10, p9 

    The article reports on a study which suggests that patients with less severe heart impairment are more likely to have better survival times with implantable cardioverter defibrillators (ICDs) than their counterparts.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics